ADVERTISEMENT
HomeMedical EducationCE/CMECE/CME Description

CE/CME

CE/CME No: CR-1301
Cognitive Screening Tools

TARGET AUDIENCE
This activity has been designed to meet the educational needs of physician assistants and nurse practitioners in primary care with patients at risk for dementia, delirium, and other forms of cognitive impairment.
 
• Original Release Date: January 2013
 
• Expiration Date: January 31, 2014
 
• Estimated Time to Complete This Activity: 1 hour
 
• Medium: Printed journal and online CE/CME
Release date: January 2013
Termination date: January 31, 2014
Estimated Time to Complete this Activity: 0 hour
Medium:

PROGRAM OVERVIEW

The primary objective of this educational initiative is to provide clinicians in primary care with the most up-to-date information regarding currently available screening tools for cognitive impairment, in particular for use in elderly patients.


EDUCATIONAL OBJECTIVES
After completing this activity, the participant should be better able to:

• Discuss factors that contribute to the growing incidence of dementia in older adults and the ramifications of undiagnosed cognitive dysfunction in this age-group.
 
• Explain the importance of early detection of cognitive changes as a first step toward accurate diagnosis of dementia, delirium, or other forms of cognitive dysfunction.
 
• Describe at least eight currently available cognitive screening tools in terms of administration time, cognitive functions assessed, and associated benefits for specific patient groups or administrative settings.
 

• Discuss associated clinical instruments used to stage cognitive decline, assess function in cognitively impaired patients, and identify acute confusion and delirium.

FACULTY

Freddi Segal-Gidan, PA-C, PhD, is Director of the Rancho/University of Southern California (USC) California Alzheimer’s Disease Center in Downey, and is an Assistant Clinical Professor in the departments of Neurology and Family Medicine at the Keck School of Medicine, USC, in Los Angeles, and an Assistant Clinical Professor of Gerontology at the L. Davis School of Gerontology at USC. She is a member of the Clinician Reviews editorial board.


ACCREDITATION STATEMENT

 

PHYSICIAN ASSISTANTS
This program has been reviewed and is approved for a maximum of 1.0 hour of American Academy of Physician Assistants (AAPA) Category I CME credit by the Physician Assistant Review Panel. Approval is valid for one year from the issue date of January 2013. Participants may submit the self-assessment at any time during that period.
 
This program was planned in accordance with AAPA’s CME Standards for Enduring Material Programs and for Commercial Support of Enduring Material Programs.
 
Successful completion of the self-assessment is required to earn Category I CME credit. Successful completion is defined as a cumulative score of at least 70% correct.
 
NURSE PRACTITIONERS
This program has been approved by the Nurse Practitioner Association New York State (The NPA) for 1.0 contact hour.

DISCLOSURE OF CONFLICTS OF INTEREST

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity: Freddi Segal-Gidan, PA-C, PhD, reported no significant financial relationship with any commercial entity related to this activity.


METHOD OF PARTICIPATION
There is no fee for participating in and receiving CME credit for Clinician Reviews’ January 2013 CE/CME activity. During the period January 2013 through January 31, 2014, participants must 1) read the learning objectives and faculty disclosures; 2) study the educational activity; 3) go to www.clinicianreviews.com/CECourses.aspx and follow links to the posttest for this activity; 4) complete the 10-question posttest by recording the best answer to each question; and 5) record their response to each of the additional evaluation questions.
 
If you have any questions, e-mail CR.evaluations@qhc.com. Upon successful completion of an online posttest, with a score of 70% or better, and the completion of the online activity evaluation form, a statement of credit will be made available immediately.

DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. AAPA, The NPA, and Quadrant HealthCom Inc. do not recommend the use of any agent outside of the labeled indications.
 
The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of AAPA, The NPA, or Quadrant HealthCom Inc. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and the possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Quick Poll
Which of the following is NOT in the differential for heparin-induced thrombocytopenia?



Submit Answer
View Results
Most Popular